Clinical Trial Update: Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking [Phase 2]

View source ↗

Summary

Phase 2 trial update on memantine hydrochloride for helping cancer survivors stop smoking.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Prostate Cancer
• Tobacco Use Disorder

Drugs mentioned

• MEMANTINE HYDROCHLORIDE (Memantine hydrochloride)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Breast Cancer, Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-01-26